Bioenvision Reports Second Quarter 2007 Financial Results; Evoltra(R) Sales Double over Last Quarter.
Business Wire › February 08, 2007
Linked as:
Extract
Bioenvision Reports Second Quarter 2007 Financial Results; Evoltra(R) Sales Double over Last Quarter.
NEW YORK -- Bioenvision, Inc. (NasdaqGM:BIVN) today announced financial results for the second quarter ended December 31, 2006.
Results and recent events include: * Bioenvision marks record quarterly revenue of $4.5 million as Evoltra([R])(clofarabine) sales doubled from the first quarter of 2007 * Bioenvision files with the EMeA for label extension of Evoltra([R]) in elderly A...See the full content of this document
Sponsored links
